{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:36:15Z","timestamp":1766158575825},"reference-count":30,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2020]]},"DOI":"10.1620\/tjem.252.133","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T22:07:24Z","timestamp":1602022044000},"page":"133-141","source":"Crossref","is-referenced-by-count":7,"title":["Multidisciplinary Approach to Prevent &lt;i&gt;de novo&lt;\/i&gt; Hepatitis B in Patients with Rheumatoid Arthritis"],"prefix":"10.1620","volume":"252","author":[{"given":"Ryu","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Osaki Citizen Hospital"},{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Osaki Citizen Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Osaki Citizen Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinako","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Osaki Citizen Hospital"},{"name":"Department of Nephrology and Endocrinology, Osaki Citizen Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soshi","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Osaki Citizen Hospital"},{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Osaki Citizen Hospital"},{"name":"Department of Nephrology and Endocrinology, Osaki Citizen Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Ohyanagi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Osaki Citizen Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makio","family":"Gamoh","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Osaki Citizen Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","unstructured":"Akashi, K., Saegusa, J., Nakamachi, Y., Nakazawa, T., Kumagai, S. &amp; Morinobu, A. (2016)  Hepatitis B virus reactivation following salazosulfapyridine monotherapy in a patient with rheumatoid arthritis.  <i>Intern. Med.<\/i>, 55, 1371-1373."},{"key":"2","unstructured":"Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D.T., Bingham, C.O.  3rd, Birnbaum, N.S., Burmester, G.R., Bykerk, V.P., Cohen, M.D., Combe, B., Costenbader, K.H., Dougados, M., Emery, P., Ferraccioli, G., et al. (2010)  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.  <i>Ann. Rheum. Dis.<\/i>, 69, 1580-1588."},{"key":"3","unstructured":"Chen, M.H., Chen, M.H., Liu, C.Y., Tsai, C.Y., Huang, D.F., Lin, H.Y., Lee, M.H. &amp; Huang, Y.H. (2017)  Hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologics treatment.  <i>J. Infect. Dis.<\/i>, 215, 566-573."},{"key":"4","unstructured":"Duhart, B.T.  Jr., Honaker, M.R., Shokouh-Amiri, M.H., Riely, C.A., Vera, S.R., Taylor, S.L., Al-jedai, A.H. &amp; Gaber, A.O. (2003)  Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation.  <i>Transpl. Infect. Dis.<\/i>, 5, 126-131."},{"key":"5","unstructured":"Fujita, M., Sugiyama, M., Sato, Y., Nagashima, K., Takahashi, S., Mizokami, M. &amp; Hata, A. (2018)  Hepatitis B virus reactivation in patients with rheumatoid arthritis: analysis of the National Database of Japan.  <i>J. Viral Hepat.<\/i>, 25, 1312-1320."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Fukuda, W., Hanyu, T., Katayama, M., Mizuki, S., Okada, A., Miyata, M., Handa, Y., Hayashi, M., Koyama, Y., Arii, K., Kitaori, T., Hagiyama, H., Urushidani, Y., Yamasaki, T., Ikeno, Y., et al. (2019)  Risk stratification and clinical course of hepatitis B virus reactivation in rheumatoid arthritis patients with resolved infection: final report of a multicenter prospective observational study at Japanese Red Cross Hospital.  <i>Arthritis Res. Ther.<\/i>, 21, 255.","DOI":"10.1186\/s13075-019-2053-1"},{"key":"7","unstructured":"Harigai, M., Mochida, S., Mimura, T., Koike, T. &amp; Miyasaka, N. (2014)  A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy.  <i>Mod. Rheumatol.<\/i>, 24, 1-7."},{"key":"8","unstructured":"Inoue, T. &amp; Tanaka, Y. (2016)  Hepatitis B virus and its sexually transmitted infection: an update.  <i>Microb. Cell<\/i>, 3, 420-437."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Koga, T., Okada, A., Fukuda, T., Hidaka, T., Ishii, T., Ueki, Y., Kodera, T., Nakashima, M., Takahashi, Y., Honda, S., Horai, Y., Watanabe, R., Okuno, H., Aramaki, T., Izumiyama, T., et al. (2016)  Prognostic factors toward clinically relevant radiographic progression in patients with rheumatoid arthritis in clinical practice: a Japanese multicenter, prospective longitudinal cohort study for achieving a treat-to-target strategy.  <i>Medicine (Baltimore)<\/i>, 95, e3476.","DOI":"10.1097\/MD.0000000000003476"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Koga, T., Okada, A., Fukuda, T., Hidaka, T., Ishii, T., Ueki, Y., Kodera, T., Nakashima, M., Takahashi, Y., Honda, S., Horai, Y., Watanabe, R., Okuno, H., Aramaki, T., Izumiyama, T., et al. (2017)  Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: a post hoc analysis of a nationwide cohort in Japan.  <i>PLoS One<\/i>, 12, e0175281.","DOI":"10.1371\/journal.pone.0175281"},{"key":"11","doi-asserted-by":"publisher","unstructured":"Kondo, H., Watanabe, R., Okazaki, S., Kuriyama, K., Harigae, H. &amp; Fujii, H. (2019)  Coexistence of rheumatoid arthritis and systemic lupus erythematosus is still rare in the biologic era: report of seven cases and literature review.  <i>Mod. Rheumatol.<\/i>, doi: 10.1080\/14397595.2019.1682795.  [Epub ahead of print].","DOI":"10.1080\/14397595.2019.1682795"},{"key":"12","unstructured":"Lee, W.M.(1997)  Hepatitis B virus infection.  <i>N. Engl. J. Med.<\/i>, 337, 1733-1745."},{"key":"13","doi-asserted-by":"crossref","unstructured":"Lin, T.C., Hashemi, N., Kim, S.C., Yang, Y.K., Yoshida, K., Tedeschi, S., Desai, R. &amp; Solomon, D.H. (2018)  Practice pattern of hepatitis B testing in rheumatoid arthritis patients: a cross-national comparison between the US and Taiwan.  <i>Arthritis Care Res. (Hoboken)<\/i>, 70, 30-38.","DOI":"10.1002\/acr.23241"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Loomba, R. &amp; Liang, T.J. (2017)  Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions.  <i>Gastroenterology<\/i>, 152, 1297-1309.","DOI":"10.1053\/j.gastro.2017.02.009"},{"key":"15","unstructured":"Matsuzaki, T., Eguchi, K., Nagao, N., Tsuji, S., Aramaki, T., Terada, K., Iwatsu, S., Tokimura, I., Kamo, Y., Oda, H., Kinoshita, N., Miyaaki, H., Taura, N., Ichikawa, T., Kawakami, A., et al. (2018)  Hepatitis B virus reactivation in patients with rheumatoid arthritis: a single-center study.  <i>Mod. Rheumatol.<\/i>, 28, 808-813."},{"key":"16","unstructured":"Mori, S.(2011)  Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and\/or nonbiological disease-modifying antirheumatic drugs.  <i>Mod. Rheumatol.<\/i>, 21, 621-627."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Okazaki, S., Watanabe, R., Harigae, H. &amp; Fujii, H. (2020)  Better retention of abatacept is associated with high rheumatoid factor: a five-year follow-up study of patients with rheumatoid arthritis.  <i>Tohoku J. Exp. Med.<\/i>, 250, 153-159.","DOI":"10.1620\/tjem.250.153"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Smolen, J.S., Aletaha, D. &amp; McInnes, I.B. (2016)  Rheumatoid arthritis.  <i>Lancet<\/i>, 388, 2023-2038.","DOI":"10.1016\/S0140-6736(16)30173-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Smolen, J.S., Landew\u00e9, R.B.M., Bijlsma, J.W.J., Burmester, G.R., Dougados, M., Kerschbaumer, A., McInnes, I.B., Sepriano, A., van Vollenhoven, R.F., de Wit, M., Aletaha, D., Aringer, M., Askling, J., Balsa, A., Boers, M., et al. (2020)  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.  <i>Ann. Rheum. Dis.<\/i>, 79, 685-699.","DOI":"10.1136\/annrheumdis-2019-216655"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Takeuchi, T., Yamanaka, H., Ishiguro, N., Miyasaka, N., Mukai, M., Matsubara, T., Uchida, S., Akama, H., Kupper, H., Arora, V. &amp; Tanaka, Y. (2014)  Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study.  <i>Ann. Rheum. Dis.<\/i>, 73, 536-543.","DOI":"10.1136\/annrheumdis-2012-202433"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Tamori, A., Koike, T., Goto, H., Wakitani, S., Tada, M., Morikawa, H., Enomoto, M., Inaba, M., Nakatani, T., Hino, M. &amp; Kawada, N. (2011)  Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.  <i>J. Gastroenterol.<\/i>, 46, 556-564.","DOI":"10.1007\/s00535-010-0367-5"},{"key":"22","unstructured":"Tanaka, E. &amp; Urata, Y. (2012)  Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-alpha inhibitors.  <i>Hepatol. Res.<\/i>, 42, 333-339."},{"key":"23","unstructured":"Tomiyama, F., Watanabe, R., Ishii, T., Kamogawa, Y., Fujita, Y., Shirota, Y., Sugimura, K., Fujii, H. &amp; Harigae, H. (2016)  High prevalence of acute exacerbation of interstitial lung disease in Japanese patients with systemic sclerosis.  <i>Tohoku J. Exp. Med.<\/i>, 239, 297-305."},{"key":"24","unstructured":"Urata, Y., Uesato, R., Tanaka, D., Kowatari, K., Nitobe, T., Nakamura, Y. &amp; Motomura, S. (2011)  Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients.  <i>Mod. Rheumatol.<\/i>, 21, 16-23."},{"key":"25","doi-asserted-by":"crossref","unstructured":"Watanabe, K., Takase, K., Ohno, S., Ideguchi, H., Nozaki, A. &amp; Ishigatsubo, Y. (2012)  Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate.  <i>Mod. Rheumatol.<\/i>, 22, 470-473.","DOI":"10.3109\/s10165-011-0521-9"},{"key":"26","unstructured":"Watanabe, R., Ishii, T. &amp; Harigae, H. (2015)  Pretreatment screening for hepatitis B virus infection in patients with systemic lupus erythematosus.  <i>Tohoku J. Exp. Med.<\/i>, 237, 9-15."},{"key":"27","unstructured":"Watanabe, R., Ishii, T., Kobayashi, H., Asahina, I., Takemori, H., Izumiyama, T., Oguchi, Y., Urata, Y., Nishimaki, T., Chiba, K., Komatsuda, A., Chiba, N., Miyata, M., Takagi, M., Kawamura, O., et al. (2014)  Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter survey.  <i>Tohoku J. Exp. Med.<\/i>, 233, 129-133."},{"key":"28","unstructured":"Watanabe, R., Ishii, T., Nakamura, K., Shirai, T., Tajima, Y., Fujii, H. &amp; Harigae, H. (2013)  Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy.  <i>Mod. Rheumatol.<\/i>, 23, 1094-1100."},{"key":"29","doi-asserted-by":"crossref","unstructured":"Watanabe, T., Fukae, J., Fukaya, S., Sawamukai, N., Isobe, M., Matsuhashi, M., Shimizu, M., Akikawa, K., Tanimura, K., Atsumi, T. &amp; Koike, T. (2019)  Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.  <i>Int. J. Rheum. Dis.<\/i>, 22, 574-582.","DOI":"10.1111\/1756-185X.13401"},{"key":"30","unstructured":"Yoshida, M., Watanabe, R., Ishii, T., Machiyama, T., Akita, K., Fujita, Y., Shirota, Y., Sugimura, K., Fujii, H., Shimokawa, H. &amp; Harigae, H. (2016)  Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience.  <i>Int. J. Rheum. Dis.<\/i>, 19, 87-94."}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/252\/2\/252_133\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T03:51:27Z","timestamp":1602301887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/252\/2\/252_133\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.252.133","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}